Item 3.02 Unregistered Sales of Equity Securities

On January 28, 2020, vTv Therapeutics Inc. (the "Company") exercised its right to cause MacAndrews & Forbes Group LLC (the "Investor") to purchase 1,250,000 shares of the Company's Class A common stock at a per share price of $1.60 pursuant to the terms of the letter agreement between the Company and the Investor dated December 23, 2019 (the "December 2019 Letter Agreement"). The Investor funded $2.0 million to the Company in exchange for 1,250,000 shares of Class A common stock following the execution of definitive documentation by and between the Company and the Investor.

The foregoing disclosure regarding the December 2019 Letter Agreement is qualified in its entirety by reference to the December 2019 Letter Agreement, a copy of which will be filed as an exhibit to the Company's Annual Report on Form 10-K for the year ending December 31, 2019.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses